Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors ...Oxford Academic
academic.oup.com
von MP Smith · · Zitiert von: 110 — (RH, RM). Search for other works by this author on: Oxford Academic · PubMed · Google Scholar. Claudia Wellbrock. Claudia Wellbrock. Affiliations of authors ... von MP Smith · · Zitiert von: 110 — (RH, RM). Search for other works by this author on: Oxford Academic · PubMed · Google Scholar. Claudia Wellbrock. Claudia Wellbrock. Affiliations of authors ...
Molecular Pathways: Maintaining MAPK Inhibitor Sensitivity by ...aacrjournals.org
aacrjournals.org
von MP Smith · · Zitiert von: 55 — ... Claudia Wellbrock. Claudia Wellbrock *. Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester ... von MP Smith · · Zitiert von: 55 — ... Claudia Wellbrock. Claudia Wellbrock *. Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester ...
Combination of MEK and SRC inhibition suppresses BioMedSearchwww.biomedsearch.com/attachments ukmss pdf
www.biomedsearch.com
BRAF downstream effector MEK. *…sponding author: Claudia Wellbrock, University of Manchester Michael Smith Building Oxford Road Manchester M13 9PT ...
Alle Infos zum Namen "Claudia Wellbrock"
A PAX3/BRN2 rheostat controls the dynamics of BRAF ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von MP Smith · · Zitiert von: 40 — ... Claudia Wellbrock. Affiliations. 1 Manchester Cancer Research Centre, Faculty of Biology, Medicine & Health, Division of Cancer Sciences, The University of ... von MP Smith · · Zitiert von: 40 — ... Claudia Wellbrock. Affiliations. 1 Manchester Cancer Research Centre, Faculty of Biology, Medicine & Health, Division of Cancer Sciences, The University of ...
Glucose availability controls ATF4-mediated MITF ...Oncotarget
www.oncotarget.com
von J Ferguson · · Zitiert von: 52 — https://doi.org oncotarget Jennifer Ferguson, Michael Smith, Isabel Zudaire, Claudia Wellbrock, Imanol Arozarena. von J Ferguson · · Zitiert von: 52 — https://doi.org oncotarget Jennifer Ferguson, Michael Smith, Isabel Zudaire, Claudia Wellbrock, Imanol Arozarena.
Oxidative Stress from DGAT1 Oncoprotein Inhibition in ...Research Explorer The University of Manchester
research.manchester.ac.uk
von D Wil… · · Zitiert von: 22 — Dunn, Claudia Wellbrock, Paul Lorigan, Craig Ceol, Chiara Francavilla, Michael SmithAdam Hurlstone Show 1 more. Show less. Division of Immunology, Immunity to ... von D Wil… · · Zitiert von: 22 — Dunn, Claudia Wellbrock, Paul Lorigan, Craig Ceol, Chiara Francavilla, Michael SmithAdam Hurlstone Show 1 more. Show less. Division of Immunology, Immunity to ...
Targeting endothelin receptor signalling overcomes ...EMBO Press
www.embopress.org
von MP Smith · · Zitiert von: 71 — ... Claudia Wellbrock https://orcid.org ukAuthor Information. EMBO Mol Med. (2017). 9: https://doi ... von MP Smith · · Zitiert von: 71 — ... Claudia Wellbrock https://orcid.org ukAuthor Information. EMBO Mol Med. (2017). 9: https://doi ...
A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated ...mdanderson.elsevierpure.com › fingerprints
mdanderson.elsevierpure.com
Michael P. Smith, Sareena Rana, Jennifer Ferguson, Emily J. Rowling, Keith T. Flaherty, Jennifer A. Wargo, Richard Marais, Claudia Wellbrock.
Biomarker accessible and chemically addressable mechanistic subtypes...
researchers.mq.edu.au
... Zaman, Tracy I. Rosales, Ugur Eskiocak, Michael P. Smith, Jessica Sudderth, Kakajan Komurov, Ralph J. Deberardinis, Claudia Wellbrock, Michael A. Davies, ...
Overcoming resistance to BRAF inhibitors - Arozarena - Annals of ...atm.amegroups.com › article › view › html
atm.amegroups.com
Claudia Wellbrock. Manchester Cancer Research Centre, The University of Manchester, Faculty of Biology, Medicine and Health, Michael Smith Building, Oxford ...
Biomarker accessible and chemically addressable ...utsouthwestern.pure.elsevier.com › ...
utsouthwestern.pure.elsevier.com
... P. Smith, Jessica Sudderth, Kakajan Komurov, Ralph J. Deberardinis, Claudia Wellbrock, Michael A. Davies, Jennifer A. Wargo, Yonghao Yu
MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide...
www.research.ed.ac.uk
... Michael P Smith, Rachel White, Ibai Goicoechea, Jorge Barriuso, Chris Jones, Geoffrey P Margison, Juan C Acosta, Claudia Wellbrock, Imanol Arozarena.
An adaptive signaling network in melanoma inflammatory niches ...mdanderson.elsevierpure.com › publications › an-ad...
mdanderson.elsevierpure.com
· ... Zachary A. Cooper, Alexandre Reuben, Jesus Gil, Keith T. Flaherty, Jennifer A. Wargo, William Vermi, Michael P. Smith, Claudia Wellbrock, ...
Osteoblasts contribute to a protective niche that supports melanoma ...www.x-mol.com › paper
en.x-mol.com
· ... Ferguson,Daniel J Wil…,Sophie McEntegart,Andrew P Badrock,Mitch Levesque,Reinhard Dummer,Claudia Wellbrock,Michael P Smith.
Targeting MITF in the tolerance-phase | Oncotarget
www.oncotarget.com
https://doi.org oncotarget Imanol Arozarena, Michael P. Smith, Claudia Wellbrock
sortiert nach Relevanz / Datum